Multiple Assemblies exist for SMTL entry 7uas
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization; X-RAY DIFFRACTION 1.81 Å

	SMTL ID 7uas.1 Ligands (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one Polypeptides WD repeat-containing protein 5 Oligo-state monomer
	SMTL ID 7uas.2 Ligands (5P)-2-[(S)-cyclopropyl(4-methylpyridin-2-yl)methyl]-5-[1-ethyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-[(2-methyl-1H-imidazol-1-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one Polypeptides WD repeat-containing protein 5 Oligo-state monomer